Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07761299
Versius Robotic Surgery in the NHS: A Multi-Specialty Retrospective StudyCMR Surgical LtdNot Yet Recruiting
NCT07761299Not Yet Recruiting
—
Versius Robotic Surgery in the NHS: A Multi-Specialty Retrospective StudyCMR Surgical Ltd
NCT07760675
Evaluating in Person Curriculum for Educating Obstetrical Residents on Better Caring for 2 Spirit Metis Patients Using and AI Assisted OSCE.Canadian Institutes of Health Research (CIHR)Not Yet RecruitingNot Applicable
NCT07760675Not Yet Recruiting
Not Applicable
Evaluating in Person Curriculum for Educating Obstetrical Residents on Better Ca...Canadian Institutes of He...
NCT07761429
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment of Cancer of Unknown Primary (CUP)Shandong New Time Pharmaceutical Co., LTDRecruitingPhase 2
NCT07761429Recruiting
Phase 2
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Tr...Shandong New Time Pharmac...
NCT07761871
Exercise and Nutritional Intervention in Patients With Melanoma Receiving ImmunotherapyInstitute of Oncology LjubljanaRecruitingNot Applicable
NCT07761871Recruiting
Not Applicable
Exercise and Nutritional Intervention in Patients With Melanoma Receiving Immuno...Institute of Oncology Lju...
NCT07760857
Investigation of an Intelligent Centre-adaptive Multi-modal Fusion Framework (Cad- MMFF) to Overcome Unnecessary Prostate Biopsies and Optimize MRI UtilizationChinese University of Hong KongNot Yet Recruiting
NCT07760857Not Yet Recruiting
—
Investigation of an Intelligent Centre-adaptive Multi-modal Fusion Framework (Ca...Chinese University of Hon...
NCT07760714
A Real-World Study of Treatment Patterns, Tolerability and Effectiveness of CDK4/6 Inhibition in HR+, HER2-negative Metastatic Breast Cancer PatientsNovartis PharmaceuticalsCompleted
NCT07760714Completed
—
A Real-World Study of Treatment Patterns, Tolerability and Effectiveness of CDK4...Novartis Pharmaceuticals
NCT07761078
Jingwanhong for BedsoresFirst Teaching Hospital of Tianjin University of Traditional Chinese MedicineNot Yet Recruiting
NCT07761065
Efficiency of Microosteoperforation for Accelerating Posterior Segment Intrusion in Skeletal Open Bite CasesAin Shams UniversityCompletedNot Applicable
NCT07761065Completed
Not Applicable
Efficiency of Microosteoperforation for Accelerating Posterior Segment Intrusion...Ain Shams University
NCT07761286
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular CarcinomaCSPC Megalith Biopharmaceutical Co.,Ltd.Not Yet RecruitingPhase 1
NCT07761286Not Yet Recruiting
Phase 1
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection f...CSPC Megalith Biopharmace...
NCT07760987
Virtual Reality During Periodontal FrenectomyBilecik Seyh Edebali UniversitesiNot Yet RecruitingNot Applicable
NCT07760987Not Yet Recruiting
Not Applicable
Virtual Reality During Periodontal FrenectomyBilecik Seyh Edebali Univ...
NCT07761520
Prevention of Ischemia in Aneurysmal Subarachnoid Hemorrhage Through Remote Ischemic PreconditioningCentre Hospitalier Universitaire de NiceNot Yet RecruitingNot Applicable
NCT07761520Not Yet Recruiting
Not Applicable
Prevention of Ischemia in Aneurysmal Subarachnoid Hemorrhage Through Remote Isch...Centre Hospitalier Univer...
NCT07759440
Clinical Outcomes of Transconjunctival Vs Transcutaneous Approaches in Orbital Fracture RepairAlexandria UniversityRecruitingNot Applicable
NCT07759440Recruiting
Not Applicable
Clinical Outcomes of Transconjunctival Vs Transcutaneous Approaches in Orbital F...Alexandria University
NCT07760272
Effect Of Intracuff Dexamethasone On Postoperative Sore Throat In Patients Undergoing Laparoscopic CholecystectomyB.P. Koirala Institute of Health SciencesNot Yet RecruitingNot Applicable
NCT07760272Not Yet Recruiting
Not Applicable
Effect Of Intracuff Dexamethasone On Postoperative Sore Throat In Patients Under...B.P. Koirala Institute of...
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07761416
Opportunistic Salpingectomy During Bariatric Surgery for Ovarian Cancer PreventionSt. Joseph's Healthcare HamiltonNot Yet RecruitingEarly Phase 1
NCT07761416Not Yet Recruiting
Early Phase 1
Opportunistic Salpingectomy During Bariatric Surgery for Ovarian Cancer Preventi...St. Joseph's Healthcare H...
NCT07761754
The Effect of Hydration on the Prevention of CI-AKI in STEMI Patients Undergoing Primary PCI (Hydro-AKI Trial)Assiut UniversityNot Yet RecruitingNot Applicable
NCT07761754Not Yet Recruiting
Not Applicable
The Effect of Hydration on the Prevention of CI-AKI in STEMI Patients Undergoing...Assiut University
NCT07761208
Turkish Version of the Pictorial Pain Interference QuestionnaireIstinye UniversityNot Yet Recruiting
NCT07761208Not Yet Recruiting
—
Turkish Version of the Pictorial Pain Interference QuestionnaireIstinye University
NCT07760077
Phase I Study of QLS1510 Tablets in Healthy ParticipantsShanghai Qilu Pharmaceutical Research and Development Center LTDNot Yet RecruitingPhase 1
NCT07760077Not Yet Recruiting
Phase 1
Phase I Study of QLS1510 Tablets in Healthy ParticipantsShanghai Qilu Pharmaceuti...
NCT07761806
Comparsion of Effect of PRP,PDE5 Inhibitor in Treatment of Erectile DysfunctionAin Shams UniversityCompletedPhase 2
NCT07761806Completed
Phase 2
Comparsion of Effect of PRP,PDE5 Inhibitor in Treatment of Erectile DysfunctionAin Shams University
NCT07759102
Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple MyelomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07759102Not Yet Recruiting
Phase 1
Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refract...National Cancer Institute...
Result Breakdown
Not yet recruiting14 (70%)
Recruiting3 (15%)
Completed3 (15%)
not_applicable9 (45%)
Not Specified5 (25%)
Phase 13 (15%)
Phase 22 (10%)
Early Phase 11 (5%)